Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy. (Q36696923)
Jump to navigation
Jump to search
scientific article published on March 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy. |
scientific article published on March 2004 |
Statements
Activity of first-line epirubicin and paclitaxel in metastatic breast cancer is independent of type of adjuvant therapy (English)
C Orlandini
B Salvadori
S Donati
E Landucci
M Rondini
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference